Nov 22, 2020 by Corinne Cardina JurneyWhat This Virus Expert Thinks About mRNA Vaccine Candidates for COVID-19Dr. Angela Rasmussen explains why news from Pfizer and Moderna's mRNA vaccine trials is so promising.
Nov 22, 2020 by Corinne Cardina JurneyHow Big Of A Deal Is mRNA Vaccine Efficacy? Imagine If It Had FailedHere's what a doctor and pandemic expert thinks about the exciting trial data coming from Pfizer and Moderna.
Nov 21, 2020 by Corinne Cardina JurneyA Doctor Explains: What Pfizer's Big Coronavirus Vaccine News MeansHere's what a pandemic expert thinks about the recent coronavirus vaccine trial data.
Nov 21, 2020 by Corinne Cardina JurneyModerna and Pfizer Investors: There's Room For Multiple mRNA Coronavirus Vaccine WinnersDr. Leo Nissola explains why these two stocks are both likely winners.
Nov 21, 2020 by Corinne Cardina JurneyWhat Investors Should Look For In Vaccine Trials' Raw DataDr. Leo Nissola shares what more he wants to see from Pfizer and Moderna as they move toward submitting their potential vaccines to the FDA.
Nov 21, 2020 by Corinne Cardina JurneyAsk A Virologist: How Do mRNA Vaccines Work?Dr. Angela Rasmussen explains how this new class of vaccines can help prevent COVID-19.
Nov 21, 2020 by Corinne Cardina JurneyAsk A Scientist: Will Virus Mutation Impact The COVID-19 Vaccine?Richard Horton, editor of The Lancet medical journal, shares his insights about what the long-term coronavirus vaccine landscape will look like.
Nov 21, 2020 by Corinne Cardina JurneyAsk A Digital Health CEO: How Has Coronavirus Changed The Wellness Industry?This app is helping people lose weight by tracking their food, and its partnership with Amazon is just the beginning.
Nov 21, 2020 by Corinne Cardina JurneyAsk A Doctor: What's A Realistic Prediction for When A Coronavirus Vaccine Will Be Available?Dr. Jeremy Brown answers the question on everyone's mind: When will there be a COVID-19 vaccine on the market?
Nov 20, 2020 by Corinne Cardina JurneyDoctor and Pandemic Expert Shares What Investors Need To Know About Coronavirus VaccinesDr. Jeremy Brown knows a lot about pandemics. Here's what he thinks about the exciting trial data coming from Pfizer and BioNTech.
Nov 19, 2020 by Corinne Cardina JurneyA Virologist Explains: mRNA Coronavirus Vaccines And What Investors Should KnowDr. Angela Rasmussen explains why news from mRNA vaccine trials is so promising and shares tips for investors thinking about buying stocks like Pfizer and Moderna.
Nov 18, 2020 by Corinne Cardina JurneyThe Motley Fool Sits Down With A Doctor About Pfizer's Coronavirus Vaccine NewsDr. Leo Nissola shares what investors need to know about the latest developments in the mRNA vaccine space.
Nov 16, 2020 by Corinne Cardina JurneyDangerous Coronavirus Vaccine Myths: Scientific Expert Explains The TruthThe Lancet's Richard Horton says we have to renegotiate our relationship with the virus and find a peaceful coexistence.
Nov 16, 2020 by Corinne Cardina JurneyCoronavirus Expert on mRNA Vaccines Versus The Old Fashioned ApproachThe Editor-in-Chief of the British medical journal The Lancet explains why Pfizer and Moderna's approach is revolutionary.
Nov 15, 2020 by Corinne Cardina JurneyCoronavirus Vaccine Stocks: How Long Will COVID-19 Immunity Last?This big question will have significant impacts on dosing, reentering society, and how often people will need vaccinations.
Nov 15, 2020 by Corinne Cardina JurneyCoronavirus Expert: 'The Virus Is Bouncing Back'New cases of COVID-19 are increasing rapidly as the winter months and holidays approach.
Nov 15, 2020 by Corinne Cardina JurneyWhat Data This Coronavirus Expert Is Looking For In Pfizer and Moderna's Vaccine TrialsIt's important to look beyond the headlines and find out more about how effective coronavirus vaccine candidates are.
Nov 14, 2020 by Corinne Cardina JurneyHere's Why Pfizer's Coronavirus Vaccine Would Be RevolutionaryIf approved and launched, an mRNA vaccine would disrupt the vaccine development landscape and go leaps and bounds toward helping the world recover from the pandemic.
Nov 14, 2020 by Corinne Cardina JurneyHow To Invest In COVID-19 Vaccine Stocks: Bet On The JockeyThe best way to pick coronavirus stocks is to make sure you trust the scientists running the company's COVID-19 program.
Nov 14, 2020 by Corinne Cardina JurneyHow To Invest In Coronavirus Vaccines: Interview with The Lancet Editor-In-ChiefHere's why this top COVID-19 expert says trusting the scientists behind the stocks is the key to investing in companies developing coronavirus vaccines.
